Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C David Andersson

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
ACS Infectious Diseases|September 18, 2024
Enzyme Dynamics Determine the Potency and Selectivity of Inhibitors Targeting Disease-Transmitting MosquitoesRashmi Kumari, Cecilia Lindgren, Rajendra Kumar, et al.
Bioorganic & Medicinal Chemistry|September 14, 2007
Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilidesAnna M Kauppi, C David Andersson, Henrik A Norberg, et al.
Plos One|March 23, 2011
Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritisIda E Andersson, C David Andersson, Tsvetelina Batsalova, et al.
Journal of Chemical Information and Modeling|February 12, 2011
Postprocessing of docked protein-ligand complexes using implicit solvation modelsAnton Lindström, Lotta Edvinsson, Andreas Johansson, et al.
Plos One|December 6, 2011
Targeting acetylcholinesterase: identification of chemical leads by high throughput screening, structure determination and molecular modelingLotta Berg, C David Andersson, Elisabet Artursson, et al.
Angewandte Chemie (International Ed. in English)|November 20, 2012
Similar but different: thermodynamic and structural characterization of a pair of enantiomers binding to acetylcholinesteraseLotta Berg, Moritz S Niemiec, Weixing Qian, et al.
Journal of Computer-Aided Molecular Design|October 30, 2014
Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesteraseC David Andersson, J Mikael Hillgren, Cecilia Lindgren, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2017
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitorsNaresh Sunduru, Mona Svensson, Mariateresa Cipriano, et al.
Journal of Medicinal Chemistry|August 30, 2013
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitorsC David Andersson, Nina Forsgren, Christine Akfur, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Screening for inhibition of Vibrio cholerae VipA-VipB interaction identifies small-molecule compounds active against type VI secretionKun Sun, Jeanette Bröms, Moa Lavander, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
ACS Infectious Diseases|September 18, 2024
Enzyme Dynamics Determine the Potency and Selectivity of Inhibitors Targeting Disease-Transmitting MosquitoesRashmi Kumari, Cecilia Lindgren, Rajendra Kumar, et al.
Bioorganic & Medicinal Chemistry|September 14, 2007
Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilidesAnna M Kauppi, C David Andersson, Henrik A Norberg, et al.
Plos One|March 23, 2011
Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritisIda E Andersson, C David Andersson, Tsvetelina Batsalova, et al.
Journal of Chemical Information and Modeling|February 12, 2011
Postprocessing of docked protein-ligand complexes using implicit solvation modelsAnton Lindström, Lotta Edvinsson, Andreas Johansson, et al.
Plos One|December 6, 2011
Targeting acetylcholinesterase: identification of chemical leads by high throughput screening, structure determination and molecular modelingLotta Berg, C David Andersson, Elisabet Artursson, et al.
Angewandte Chemie (International Ed. in English)|November 20, 2012
Similar but different: thermodynamic and structural characterization of a pair of enantiomers binding to acetylcholinesteraseLotta Berg, Moritz S Niemiec, Weixing Qian, et al.
Journal of Computer-Aided Molecular Design|October 30, 2014
Benefits of statistical molecular design, covariance analysis, and reference models in QSAR: a case study on acetylcholinesteraseC David Andersson, J Mikael Hillgren, Cecilia Lindgren, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2017
N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitorsNaresh Sunduru, Mona Svensson, Mariateresa Cipriano, et al.
Journal of Medicinal Chemistry|August 30, 2013
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitorsC David Andersson, Nina Forsgren, Christine Akfur, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Screening for inhibition of Vibrio cholerae VipA-VipB interaction identifies small-molecule compounds active against type VI secretionKun Sun, Jeanette Bröms, Moa Lavander, et al.
Pageof 3